2022 American Society of Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) Indications for Metabolic and Bariatric Surgery
Dan Eisenberg, Scott A. Shikora, Edo O. Aarts, Ali Aminian, Luigi Angrisani, Ricardo V. Cohen, Maurizio De Luca, Sílvia Leite Faria, Kasey Goodpaster, Ashraf Haddad, Jacqués Himpens, Lilian Kow, Marina Kurian, Ken Loi, Kamal Mahawar, Abdelrahman Nimeri, Mary O’Kane, Pavlos Papasavas, Jaime Ponce, Janey S.A. Pratt, Ann M. Rogers, Kimberley E. Steele, Michel Suter, Shanu N. Kothari
Abstract
Major updates to 1991 National Institutes of Health guidelines for bariatric surgery Metabolic and bariatric surgery (MBS) is recommended for individuals with a body mass index (BMI) > 35 kg/m 2 , regardless of presence, absence, or severity of co-morbidities. MBS should be considered for individuals with metabolic disease and BMI of 30-34.9 kg/m 2 . BMI thresholds should be adjusted in the Asian population such that a BMI > 25 kg/m 2 suggests clinical obesity, and individuals with BMI > 27.5 kg/m 2 should be offered MBS. Long-term results of MBS consistently demonstrate safety and efficacy. Appropriately selected children and adolescents should be considered for MBS. (Surg Obes Relat Dis 2022; https://doi.org/10.1016/j.soard.2022.08.013 ) © 2022 American Society for Metabolic and Bariatric Surgery. All rights reserved.